Cutler Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Cutler Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,400	Closed	-$3K	–	6510
2021 Q3	$3K	Buy	+5,400	New	+$149K	﹤0.01%	4937
2020 Q3	–	Sell	-1,000	Closed	-$2K	–	5458
2020 Q2	$2K	Buy	+1,000	New	+$21.5K	﹤0.01%	3907

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Cutler Group's DRNA Position: Q4 2020 in Review

Cutler Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.

Cutler Group first reported a position in DRNA in Q2 2018 and held it in 6 quarters. The position peaked at $19K in Q4 2019. 173 funds tracked by Wall St. Rank hold DRNA as of Q4 2020.

Cutler Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 100 Dicerna Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1K.
Cutler Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 6 quarters.
Cutler Group's Dicerna Pharmaceuticals, Inc. position peaked at $19K in Q4 2019.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.